Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression - PubMed (original) (raw)
Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression
Prue H Hart et al. Methods. 2002 Sep.
Abstract
There is a direct correlation between dermal mast cell prevalence in dorsal skin of different mouse strains and susceptibility to UVB-induced systemic immunosuppression; highly UV-susceptible C57BL/6 mice have a high dermal mast cell prevalence while BALB/c mice, which require considerable UV radiation for 50% immunosuppression, have a low mast cell prevalence. There is also a functional link between the prevalence of dermal mast cells and susceptibility to UVB- and cis-urocanic acid (UCA)-induced systemic immunosuppression. Mast cell-depleted mice are unresponsive to UVB or cis-UCA for systemic immunosuppression unless they are previously reconstituted at the irradiated or cis-UCA-administered site with bone marrow-derived mast cell precursors. cis-UCA does not stimulate mast cell degranulation directly. Instead, in support of studies showing that neither UVB nor cis-UCA was immunosuppressive in capsaicin-treated, neuropeptide-depleted mice, cis-UCA-stimulated neuropeptide release from sensory c-fibers which, in turn, could efficiently degranulate mast cells. Studies in mice suggested that histamine, and not tumor necrosis factor alpha (TNF-alpha), was the product from mast cells that stimulated downstream immunosuppression. Histamine receptor antagonists reduced by approximately 60% UVB and cis-UCA-induced systemic immunosuppression. Indomethacin administration to mice had a similar effect which was not cumulative with the histamine receptor antagonists. Histamine can stimulate keratinocyte prostanoid production. We propose that both histamine and prostaglandin E(2) are important in downstream immunosuppression; both are regulatory molecules supporting the development of T helper 2 cells and reduced expression of type 1 immune responses such as a contact hypersensitivity reaction.
Similar articles
- Histamine involvement in UVB- and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses.
Hart PH, Jaksic A, Swift G, Norval M, el-Ghorr AA, Finlay-Jones JJ. Hart PH, et al. Immunology. 1997 Aug;91(4):601-8. doi: 10.1046/j.1365-2567.1997.00284.x. Immunology. 1997. PMID: 9378501 Free PMC article. - Mast cells in UV-B-induced immunosuppression.
Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Hart PH, et al. J Photochem Photobiol B. 2000 Apr-May;55(2-3):81-7. doi: 10.1016/s1011-1344(00)00032-4. J Photochem Photobiol B. 2000. PMID: 10942071 Review. - A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice.
Hart PH, Grimbaldeston MA, Swift GJ, Hosszu EK, Finlay-Jones JJ. Hart PH, et al. Photochem Photobiol. 1999 Nov;70(5):807-12. Photochem Photobiol. 1999. PMID: 10568173 - Sunlight, immunosuppression and skin cancer: role of histamine and mast cells.
Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Hart PH, et al. Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):1-8. doi: 10.1046/j.1440-1681.2001.03392.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11153522 Review. - Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: link to indomethacin-inhibitable UVB-induced immunosuppression.
Jaksic A, Finlay-Jones JJ, Watson CJ, Spencer LK, Santucci I, Hart PH. Jaksic A, et al. Photochem Photobiol. 1995 Mar;61(3):303-9. doi: 10.1111/j.1751-1097.1995.tb03976.x. Photochem Photobiol. 1995. PMID: 7716191
Cited by
- Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary-lung axis.
Huang Y, Zhu L, Cheng S, Dai R, Huang C, Song Y, Peng B, Li X, Wen J, Gong Y, Hu Y, Qian L, Zhu L, Zhang F, Yu L, Yi C, Gu W, Ling Z, Ma L, Tang W, Peng L, Shi G, Zhang Y, Sun B. Huang Y, et al. Nat Commun. 2023 Sep 12;14(1):5601. doi: 10.1038/s41467-023-41319-1. Nat Commun. 2023. PMID: 37699899 Free PMC article. - Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases.
Murdaca G, Allegra A, Tonacci A, Musolino C, Ricciardi L, Gangemi S. Murdaca G, et al. Biomedicines. 2022 Aug 3;10(8):1877. doi: 10.3390/biomedicines10081877. Biomedicines. 2022. PMID: 36009422 Free PMC article. Review. - The role of mast cells in human skin cancers.
Ribatti D, Tamma R, Annese T, Crivellato E. Ribatti D, et al. Clin Exp Med. 2021 Aug;21(3):355-360. doi: 10.1007/s10238-021-00688-x. Epub 2021 Feb 12. Clin Exp Med. 2021. PMID: 33576908 Review. - Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
Rigby C, Deep G, Jain A, Orlicky DJ, Agarwal C, Agarwal R. Rigby C, et al. Mol Carcinog. 2019 Jul;58(7):1260-1271. doi: 10.1002/mc.23008. Epub 2019 Mar 25. Mol Carcinog. 2019. PMID: 30912211 Free PMC article. - A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment.
Bamji-Stocke S, van Berkel V, Miller DM, Frieboes HB. Bamji-Stocke S, et al. Metabolomics. 2018 Jun;14(6):81. doi: 10.1007/s11306-018-1376-2. Epub 2018 Jun 1. Metabolomics. 2018. PMID: 29983671 Free PMC article.